Increased red blood cell survival reduces the need of erythropoietin in hemodialyzed patients treated with exogenous glutathione and vitamin E-modified membrane.
Usberti
M
M
Servizi di Nefrologia e Dialisi, Ospedale di Leno, BS, Italia.
Bufano
G
G
Lima
G
G
Gazzotti
R M
RM
Tira
P
P
Gerardi
G
G
Di Lorenzo
D
D
D000328:Adult; D000368:Aged; D000975:Antioxidants / Q000494:pharmacology*; D002482:Cellulose; D004905:Erythrocyte Aging; D004921:Erythropoietin / Q000627:therapeutic use*; D005260:Female; D005978:Glutathione / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008567:Membranes, Artificial; D008875:Middle Aged; D018384:Oxidative Stress; D006435:Renal Dialysis; D014810:Vitamin E / Q000097:blood / Q000494:pharmacology*
D000975:Antioxidants; D008567:Membranes, Artificial; D004921:Erythropoietin; D014810:Vitamin E; D002482:Cellulose; D005978:Glutathione